WHO ICTRP trial
Comparison of Interferon-beta-1a and Dexamethasone on hospitalized patients with…
IRCT20150622022869N9 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20150622022869N9 |
|---|---|
| Public title | Comparison of Interferon-beta-1a and Dexamethasone on hospitalized patients with Covid-19. |
| Scientific title | Comparison of the effect of interferon-beta 1a and Dexamethasone in hospitalized patients with Covid - 19. |
| Primary sponsor | Yasouj University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | COVID - 19. COVID-19, virus identified;U07.1 |
| Interventions | Intervention 1: Intervention group: (combination of three drugs Remedsivir, Interferon, and Dexamethasone) Remedsivir drugs with a dose of 200 mg in the initial dose and then 100 mg daily for 5 days, Interferon-beta 1 alpha is given as a… |
| Registration date | Jul 2, 2022 |
| Target size | 176 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: